eHaRT-A for Alcoholism
(eHaRT-A Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment eHaRT-A for alcoholism?
What safety data exists for eHaRT-A or similar treatments for alcoholism?
What is the purpose of this trial?
The goal of this project is to transform a successful, face-to-face harm-reduction treatment (HaRT-A) into a digital format, creating eHaRT-A. This new platform is specifically designed for people who have experienced homelessness and an alcohol use disorder (AUD), living within the framework of permanent, supportive, Housing First (HF) facilities. We hypothesize eHaRT-A will be more effective than the standard HF services in reducing alcohol-related harm and improving the overall quality of life for participants.
Research Team
Tessa Frohe, PhD
Principal Investigator
University of Washington
Eligibility Criteria
This trial is for English-speaking adults over 21 who are registered at Housing First sites, currently drink alcohol, and meet the criteria for an Alcohol Use Disorder (AUD) as per the Diagnostic and Statistical Manual of Mental Health Disorders.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the eHaRT-A intervention, which includes tracking alcohol-related harm, setting harm-reduction goals, and discussing safer-drinking strategies
Follow-up
Participants are monitored for changes in quality of life, alcohol consumption, and harm reduction outcomes
Treatment Details
Interventions
- eHaRT-A
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Washington
Lead Sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Collaborator